Litcius/Paper detail

Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions—a single-center retrospective observational study

Maria Gontika, Charalampos Skarlis, Nikolaos Markoglou, Dimitrios Tzanetakos, Aglaia G Vakrakou, Panagiotis Toulas, George Koutsis, Maria-Eleptheria Evangelopoulos, Roser Pons, Efthimios Dardiotis, George P. Chrousos, Marinos C. Dalakas, Leonidas Stefanis, Maria Anagnostouli

2022Naunyn-Schmiedeberg s Archives of Pharmacology14 citationsDOI

Topics & Concepts

NatalizumabMedicineObservational studySingle CenterMultiple sclerosisGenotypingInternal medicineRetrospective cohort studyAdverse effectProgressive multifocal leukoencephalopathyHuman leukocyte antigenPediatricsDiseaseGenotypeImmunologyAntigenBiochemistryChemistryGeneMultiple Sclerosis Research StudiesImmunotherapy and Immune ResponsesPolyomavirus and related diseases
Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions—a single-center retrospective observational study | Litcius